| Financial Year |
March 31 2023 |
| Monetary Funds |
301,445,307.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
122,193,670.34 |
| Advances to Suppliers |
103,372,810.70 |
| Other Receivables |
6,928,190.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,341,960.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,502,279.68 |
| Total Current Assets |
709,338,293.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
104,576,732.26 |
| Investment Properties |
107,089,472.58 |
| Fixed Assetes |
762,917,719.56 |
| Under-construction Projects |
132,586,772.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,678,769.77 |
| R&D expenses |
-- |
| Goodwill |
354,232,639.10 |
| Long-Term Deferred and Prepaid Expenses |
39,567,321.40 |
| Deferred Income Tax Assets |
14,224,938.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,580,326,332.46 |
| Total Assets |
2,289,664,625.59 |
| Short-Term Loans |
318,080,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
61,000,000.00 |
| Accounts Payable |
146,834,513.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,287,293.01 |
| Taxes Payable |
13,713,208.29 |
| Interest Payable |
1,020,724.95 |
| Dividend Payable |
1,851,458.80 |
| Other payables |
28,882,020.78 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
98,500,000.00 |
| Other Current Liabilities |
4,933,624.97 |
| Sub-Total of Current Liabilities |
849,223,316.74 |
| Long-term Loans |
280,070,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
29,977,887.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,976,035.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
317,516,222.67 |
| Total Liabilities |
1,166,739,539.41 |
| Paid-In Capital(Or Share Stock) |
358,631,009.00 |
| Capital Surplus |
649,371,319.13 |
| Surplus Reserve |
25,885,921.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
58,794,242.70 |
| Minority Stockholder's Interest |
29,561,523.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,093,363,562.97 |
| Owner's Equity（Stockholder's Equity） |
1,122,925,086.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,289,664,625.59 |
